#PathosAI
LightNews LightNews
pharmaphorum.bsky.social
NEWS: #AstraZeneca has started work with tech companies #Tempus and #PathosAI on a project that aims to generate a wide-ranging and comprehensive generative artificial intelligence model for #oncology.

pharmaphorum.com/news/astraze...
AstraZeneca joins Tempus, Pathos in cancer AI project
AstraZeneca has started work with Tempus and Pathos AI on a $200m project to build a comprehensive multimodal foundation model for oncology.
pharmaphorum.com
April 24, 2025 at 12:27 PM
pharmaphorum.bsky.social
SCOOP: #EricSchadt, a serial entrepreneur and expert in #computationalbiology, is leaving his post as chief scientist at #PathosAI to start a new, stealthy venture - and signing on as #Pfizer's first #AIScholar in the process.

pharmaphorum.com/news/ai-geno...
AI, genomics expert leaves Pathos AI, will advise Pfizer
Pfizer is creating the role of AI Scholar for computational biologist Eric Schadt, who is leaving Pathos AI to start a new stealth venture.
pharmaphorum.com
August 21, 2026 at 2:17 PM
pharmaphorum.bsky.social
#PathosAI has grown its oncology pipeline by licensing a bispecific #ADC from Alphamab in a $2.2bn deal, and partnering a breast cancer candidate from #AstraZeneca. pharmaphorum.com/news/pathos-...
Pathos AI signs two cancer deals with Alphamab and AZ
Pathos AI has grown its oncology pipeline by licensing a bispecific ADC from Alphamab for $125m and partnering a breast cancer drug from AstraZeneca.
pharmaphorum.com
August 4, 2026 at 10:55 AM
emergingtechnews.bsky.social
Funding Raises: #Alphabet $12.6B Post-IPO Debt; #SYSTEX $1.2B Post-IPO; #Rippling $450M Series G; #PathosAI $365M Series D; #AI21Labs $300M Series D; #Addepar $230M Series G; #XiangdaoChuxing 1.3B yuan Series C; #Azafaros €132M Series B; #Stash $146M Series H
May 16, 2025 at 4:40 PM
wealthwise-dca.bsky.social
Tempus AI, AstraZeneca & Pathos AI Team Up on AI Oncology Model.

#TEM #TEMStock #TEMNews #TEMStockNews #TempusAI #TempusAIStock #TempusAINews #TempusAIStockNews #TempusAIAstraZeneca #AstraZeneca #AZN #AZNStock #PathosAI #Oncology #TempusAIOncology #OncologyAI #CancerAI #TempusAICancer
April 24, 2025 at 11:58 AM